Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma

BACKGROUND: Targeting cancer stem cells (CSC) may represent a future therapeutic direction for osteosarcoma (OS), which mainly relies on the identification of CSC markers. This study aimed to classify OS based on messenger ribonucleic acid (mRNA) stemness indices (mRNAsi) and construct a mRNAsi-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Jin, Chi, Lu, Xinchang, Zhang, Yan, Zhang, Yi, Wen, Jia, Liu, Yongkui, Liu, Xiaoting, Li, Jiazhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929782/
https://www.ncbi.nlm.nih.gov/pubmed/36819514
http://dx.doi.org/10.21037/atm-22-6011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929782/
https://www.ncbi.nlm.nih.gov/pubmed/36819514
http://dx.doi.org/10.21037/atm-22-6011

Ejemplares similares